O002 A novel, optogenetics based therapy for obstructive sleep apnea

INTRODUCTION: Many obstructive sleep apnea (OSA) patients are sub-optimally treated due to poor tolerance or incomplete response to established therapies. We propose a novel stimulation therapy that sensitises the dilator muscles to light activation (‘optogenetics') and activates the muscles wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Knapman, F, Cohen, M, Kulaga, T, Lisowski, L, Lovell, N, McMullan, S, Burke, P, Bilston, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
ORAL PRESENTATIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109414/
http://dx.doi.org/10.1093/sleepadvances/zpac029.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109414/
http://dx.doi.org/10.1093/sleepadvances/zpac029.001

Ejemplares similares